MedPath

Observational Study on the Course of Plasma Glutamine Levels During Critical Illness

Completed
Conditions
Glutamine Levels
Registration Number
NCT02310035
Lead Sponsor
Medical Centre Leeuwarden
Brief Summary

Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission

Detailed Description

All patients who are admitted to the ICU after elective surgery and non-elective admissions. In both groups a total of 80 patients will be included.

(In the trials we mentioned in the introduction 80, 174 and 66 patients were included. In the study performed by Oudemans-van Straaten a decent distribution between lower and higher levels of glutamine was achieved in 80 non-elective patients.) Exclusion criteria are patients younger then 18 years and patients who need total parenteral nutrition (TPN).

The patients will receive standard care during their treatment on the ICU. Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission. Hereafter plasma glutamine will be measured daily, a plasma sample will be taken from a standard evaluation blood sample at 6.00 am during admission on the ICU.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
178
Inclusion Criteria
  • all patients admitted to the ICU
Exclusion Criteria
  • younger then 18 years and patients who need total parenteral nutrition

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
glutamine in serumfrom admission up to 8 days

glutamine level at admission and during ICU stay daily

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical Centre Leeuwarden

🇳🇱

Leeuwarden, Netherlands

© Copyright 2025. All Rights Reserved by MedPath